Risk of stroke overall and by stroke severity among newly diagnosed non-valvular atrial fibrillation patients initiating treatment with rivaroxaban versus warfarin
Event:
ESC Congress 2018
Topic:
Oral Anticoagulation
Session:
Atrial fibrillation - Stroke prevention
